Filing Details
- Accession Number:
- 0001415889-25-020200
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-23 18:09:44
- Reporting Period:
- 2025-07-22
- Filing Date:
- 2025-07-23
- Accepted Time:
- 2025-07-23 18:09:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1760542 | Hookipa Pharma Inc. | HOOK | Pharmaceutical Preparations (2834) | 815395687 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1876563 | Malte Peters | C/O Hookipa Pharma Inc. 350 Fifth Avenue, 72Nd Floor, Suite 7240 New York NY 10118 | Chief Executive Officer | No | No | No | No |
Transaction Summary
| Sold: | 29,176 shares | Avg. Price: $0.92 | Total Value: $26,841.92 |
| Number of Shares After Transactions: | 79,519 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-07-22 | 29,176 | $0.92 | 79,519 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was affected pursuant to a "sell to cover" arrangement adopted by the Issuer to satisfy the tax withholding obligations triggered by the vesting of restricted stock units granted on July 22, 2024 and does not represent a discretionary trade by the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
Billionaire Hedge Funds
